Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics
Recruiting now · Phase 3
Conditions studied: Glioma
In brief
the investigators hypothesise that 18F-FDOPA PET kinetic parameters are good biomarkers to characterise suspected LGG brain lesions that exhibit no contrast on MRI, for identifying aggressive lesions. These parameters could constitute diagnostic biomarkers for this indication. This new diagnostic tool could enhance patient care in the short term in an evolving pathology affecting socially active subjects with a poor prognosis
Key facts
- Study ID
- NCT05512403
- Run by
- Central Hospital, Nancy, France
- People needed
- 88
- Starts
- 2023-06-13
- Expected to finish
- 2026-10-30
- Last updated by the study team
- 2024-09-19
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age between 18 and 75 years old
- WHO general condition ≤2
- Identification of a unifocal brain tumour at the initial diagnosis with no contrast in the MRI and suspected to be a LGG, with biopsy/surgery envisaged within 6 months of the PET scan
- MRI performed a maximum of 3 weeks before inclusion and comprising the conventional morphological sequences (T1, T1 sequences with injection of contrast agent and T2 FLAIR).
- Subject affiliated to or beneficiary of a social security plan
- Subject having received complete information on the organisation of the research and having signed the informed consent form.
You may not qualify if…
- Multifocal brain lesions
- Contraindication to 18F-FDOPA PET
- Pregnant, parturient women or nursing mothers under Article L1121-5
- Women of childbearing age who do not have effective contraception under Article L1121-5
- Monitoring not possible
- Persons deprived of their liberty by a judicial or administrative decision under Article 1121-8, persons undergoing psychiatric treatment under Articles L. 3212-1 and L. 3213-1.
- Patients cannot simultaneously participate in an interventional research trial for the duration of the KING study
Where it is running
- CHRU Nancy — Vandœuvre-lès-Nancy, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.